Comparative efficacy and safety of different regimens of ranibizumab for neovascular age-related macular degeneration: a network meta-analysis of randomised controlled trials

OBJECTIVE: To give a comprehensive efficacy and safety ranking of different therapeutic regimens of ranibizumab for neovascular age-related macular degeneration (nAMD). DESIGN: A systematic review and network meta-analysis. METHODS: The PubMed, Embase, Cochrane Central Register of Controlled Trials,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xinyu, Meng, Lihui, Chen, Youxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Ophthalmology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925869/
https://www.ncbi.nlm.nih.gov/pubmed/33550238
http://dx.doi.org/10.1136/bmjopen-2020-040906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925869/
https://www.ncbi.nlm.nih.gov/pubmed/33550238
http://dx.doi.org/10.1136/bmjopen-2020-040906

Ejemplares similares